Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTARTtlCrH: Timing to Restart DOACs After Traumatic Intracranial Haemorrhage
NCT06322953Phase 3Recruiting
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Atrial fibrillation (AFib) and venous thromboembolism (VTE) (2 arms). Primary endpoint: Proportion of patients with haemorrhagic or thrombotic event at 12 weeks. Started Mar 2025; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT06322953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06322953.